Consult Before Starting If You Have Medical Conditions Some complaints arise from customers who used ColonBroom without realizing it was not suitable for their health status
Schakman O, Dehoux M, Bouchuari S, Delaere S, Lause P, Decroly N, Shoelson SE, Thissen JP (2012) Role of IGF-I and the TNFalpha/NF-kappaB pathway in the induction of muscle atrogenes by acute inflammation
Phase I pilot (three healthy male volunteers, subcutaneous administration, 1996, PMID 8637402), increased facial, upper-body, and buttock pigmentation persisting approximately one week after cessation of dosing was reported alongside nausea and somnolence
Incretins: a potential therapy in NAFLD Based on the impressive effect of GLP-1R agonists on body weight and also the ability of these drugs to improve liver enzymes [54], incretin-based therapy for the treatment of NAFLD is currently being explored
5 mg 2x/week subcutaneous